Key statistics
On Friday, Arrowhead Pharmaceuticals Inc (ARWR:NSQ) closed at 20.10, 17.89% above the 52 week low of 17.05 set on Oct 10, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 20.00 |
---|---|
High | 20.63 |
Low | 19.82 |
Bid | 19.53 |
Offer | 20.49 |
Previous close | 19.93 |
Average volume | 995.59k |
---|---|
Shares outstanding | 124.32m |
Free float | 118.76m |
P/E (TTM) | -- |
Market cap | 2.48bn USD |
EPS (TTM) | -4.65 USD |
Data delayed at least 15 minutes, as of Oct 25 2024 21:00 BST.
More ▼
- Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
- Arrowhead Pharmaceuticals Files for Regulatory Clearance to Initiate Phase 1/2a Study of ARO-INHBE for the Treatment of Obesity
- Arrowhead Pharmaceuticals Receives FDA Breakthrough Therapy Designation for Plozasiran
- Arrowhead Pharmaceuticals Presents New Pivotal Phase 3 Data at ESC 2024 from PALISADE Study of Plozasiran in Patients with Familial Chylomicronemia Syndrome
- Arrowhead Pharmaceuticals to Present New Phase 3 Data at ESC 2024 from PALISADE Study of Plozasiran in Patients with Familial Chylomicronemia Syndrome
- Arrowhead Pharmaceuticals to Advance Two New RNAi-Based Obesity Candidates, ARO-INHBE and ARO-ALK7, Into Clinical Studies
- Arrowhead Pharmaceuticals Reports Fiscal 2024 Third Quarter Results
- Arrowhead Pharmaceuticals Announces $500 Million Strategic Financing Facility with Sixth Street
More ▼